Overview

Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2

Status:
Recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
This study will be a multi-institutional randomized clinical trial of a short course of pre-operative antibiotic prophylaxis in addition to perioperative antibiotics prior to undergoing percutaneous nephrolithotomy. The select patient population will be those patients deemed to be at a moderately increased risk of postoperative infectious complications. These higher risk patients are those with indwelling urinary drainage tubes and those with a positive preoperative urine culture.
Phase:
N/A
Details
Lead Sponsor:
University of California, San Diego
Treatments:
Ampicillin
Anti-Bacterial Agents
Antibiotics, Antitubercular
Cefpodoxime
Cefpodoxime proxetil
Cephalexin
Ciprofloxacin
Doxycycline
Gentamicins
Nitrofurantoin
Sulfamethoxazole
Trimethoprim
Trimethoprim, Sulfamethoxazole Drug Combination